Skip to main content
. 2016 Jul 1;7(30):46899–46912. doi: 10.18632/oncotarget.10380

Figure 4. Inhibitors block the HNG-mediated activation of ERK, AKT, and STAT3. (.

Figure 4

A) Representative western blots showing ERK, AKT, and STAT3 activation in conjunction with specific inhibitors under serum free conditions (n = 3). Quantification of (C) AKT and (D) ERK activation. Data are reported as mean ± SEM of 4 independent experiments. ***p < 0.001, *p < 0.05. Abbreviations: PD, PD98059; LY, LY294002; JAKI, JAK inhibitor I; GP, Anti-GP130 antibody.